You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, June 9, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
       
       

      CME / ABIM MOC / CE

      Hot Topics in Lung Cancer

      • Authors: Ibiayi Dagogo-Jack, MD; Melina Elpi Marmarelis, MD, MSCE; Aadel Chaudhuri, MD, PhD
      • CME / ABIM MOC / CE Released: 3/31/2023
      • Valid for credit through: 3/31/2024
      Start Activity

      • Credits Available

        Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

        ABIM Diplomates - maximum of 0.50 ABIM MOC points

        Nurses - 0.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

        Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

        You Are Eligible For

        • Letter of Completion
        • ABIM MOC points

      Target Audience and Goal Statement

      This activity is intended for physicians, nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists.

      The goal of this activity is for the learner to be better able to provide expert guidance on important and dynamic topics in lung cancer care.

      Upon completion of this activity, participants will:

      • Have increased knowledge regarding the
        • Current management of mesothelioma
        • Role of liquid biopsy in lung cancer
      • Demonstrate greater confidence in their ability to
        • Manage patients with lung cancer in light of emerging issues and changing practice patterns (eg, long-term survival, age at diagnosis)

      Disclosures

      Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

      All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

      Faculty

      • Ibiayi Dagogo-Jack, MD

        Assistant Professor of Medicine
        Harvard Medical School
        Thoracic Oncologist
        Internal Medicine/Medical Oncology
        Massachusetts General Hospital
        Boston, Massachusetts

        Disclosures

        Ibiayi Dagogo-Jack, MD, has the following relevant financial relationships:
        Consultant or advisor for: AstraZeneca; Bayer; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; BostonGene; Genentech; Janssen; Novocure; Pfizer, Inc.; Sanofi/Genzyme; Syros; Xcovery Vision
        Speaker or member of speakers bureau for: Aptitude Health; DAVA Oncology
        Research funding from: Array BioPharma; Genentech; Novartis; Pfizer, Inc.; Vivace

      • Melina Elpi Marmarelis, MD, MSCE

        Assistant Professor
        Division of Hematology/Oncology
        Perelman School of Medicine
        University of Pennsylvania
        Philadelphia, Pennsylvania

        Disclosures

        Melina Elpi Marmarelis, MD, MSCE, has the following relevant financial relationships:
        Consultant or advisor for: AstraZeneca; Blueprint Pharmaceuticals (former); Bristol Myers Squibb Company (former); Boehringer Ingelheim Pharmaceuticals, Inc.; Ikena Oncology; Janssen (former); Novocure (former); Takeda (former); Thermo Fisher Scientific Inc.
        Research funding from: AstraZeneca; Lilly; Merck; Trizell
        Owns stock (publicly traded) in: bluebird bio, Inc.; Gilead Sciences, Inc.; Merck; Novartis; Pfizer, Inc.; Portola Pharmaceuticals, Inc.
        Other: Medical Writing Support for Novartis

      • Aadel Chaudhuri, MD, PhD

        Assistant Professor of Radiation Oncology
        Cancer Biology Division, Genetics
        Biomedical Engineering and Computer Science & Engineering
        Washington University School of Medicine
        St Louis, Missouri

        Disclosures

        Aadel Chaudhuri, MD, PhD, has the following relevant financial relationships:
        Consultant or advisor for: AlphaSights; AstraZeneca; Daiichi Sankyo, Inc.; DeciBio; Geneoscopy; Guidepoint; Illumina; Roche; Tempus Labs, Inc.
        Patent beneficiary of: Biocognitive Labs; Droplet Biosciences; LiquidCell Dx; Tempus Labs, Inc.
        Stock options from: Geneoscopy

      Editor

      • Deborah Grainger, PhD

        Medical Education Director, WebMD Global, LLC

        Disclosures

        Deborah Grainger, PhD, has no relevant financial relationships.

      • John Churchwell, PhD

        Medical Education Director, Medscape, LLC

        Disclosures

        John Churchwell, PhD, has the following relevant financial relationships:
        Formerly employed by an ineligible company: Medtronic, Inc.

      Compliance Reviewer/Nurse Planner

      • Stephanie Corder, ND, RN, CHCP

        Associate Director, Accreditation and Compliance, Medscape, LLC

        Disclosures

        Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

      Peer Reviewer

      This activity has been peer reviewed and the reviewer has no relevant financial relationships.

      Accreditation Statements



      In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

        For Physicians

      • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

        The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

        College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 Credit™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

        Contact This Provider

        For Nurses

      • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

        Contact This Provider

        For Pharmacists

      • Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-23-086-H01-P).

        Contact This Provider

      For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

      Instructions for Participation and Credit

      There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

      This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

      Follow these steps to earn CME/CE credit*:

      1. Read about the target audience, learning objectives, and author disclosures.
      2. Study the educational content online or print it out.
      3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

      You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

      *The credit that you receive is based on your user profile.

      < CLINICAL ADVANCES IN Perspectives in Lung Cancer Care
      From Medscape Education Oncology
      CME / ABIM MOC / CE

      Hot Topics in Lung Cancer

      Authors: Ibiayi Dagogo-Jack, MD; Melina Elpi Marmarelis, MD, MSCE; Aadel Chaudhuri, MD, PhDFaculty and Disclosures

      CME / ABIM MOC / CE Released: 3/31/2023

      Valid for credit through: 3/31/2024

      processing....

      Contents of This CME Activity

      All sections of this activity are required for credit.

      Management of Mesothelioma in 2023: Updates on Current and Emerging Therapies

      Catch up on the state-of-the-art in the management of mesothelioma by hearing from this veteran in the field.
      Melina Elpi Marmarelis, MD, MSCE

      The Future of Liquid Biopsy: Applications for Early Detection and Non-Metastatic Lung Cancer

      Are you up to date on applications for early detection of non-metastatic lung cancer? Get up to speed with this thoughtful presentation.
      Aadel Chaudhuri, MD, PhD
       

      Learning Feedback Questions

      Please answer these questions to complement your learning experience.

      Page 1 of 5
      CME / ABIM MOC / CE Information Download Slides
      • Print
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.